Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0162871 (
abdominal aortic aneurysm
)
8,664
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Current opinions suggest that autoantibodies occurring in autoimmune diseases are generated by B-cells which primarily produce polyspecific natural autoantibodies, through either polyclonal activation or specific antigen selection of these B-cells. In this study, we compared the immunological properties (polyspecificity, fine specificity and IgG subclasses) between natural anti-actin antibodies (N-AAA) and disease-associated
AAA
(D-AAA). IgG
AAA
from sera of healthy donors, patients with autoimmune hepatitis type 1 (AIH-1) and patients with primary biliary cirrhosis (PBC) were affinity-purified on actin immunoadsorbent and tested initially for polyspecificity against various cytoskeleton proteins by enzyme-linked immunosorbent assay (ELISA). Fine specificity was studied by Western blotting using proteolytic peptides of actin and by ELISA using synthetic 12 mer peptides, spanning the 221-377 aa sequence of actin. Results showed that both N-
AAA
and D-
AAA
are polyspecific. Nevertheless, D-
AAA
from both diseases showed a specific reactivity pattern as compared to N-
AAA
, against the 16 kDa C-terminal (229-377 aa) proteolytic peptide of actin and more specifically against the
P36
synthetic peptide (351-362 aa). Quantitation of
AAA
IgG subclasses revealed that IgG1 and IgG3 were specifically increased in D-
AAA
from AIH-1 and PBC, respectively, as compared to N-
AAA
. We conclude that D-
AAA
are differentiated from N-
AAA
in terms of fine specificity and IgG subclasses, probably through specific antigen selection of B-cells primarily producing N-
AAA
.
...
PMID:Fine specificity and subclasses of IgG anti-actin autoantibodies differ in health and disease. 1279 19